Galena Biopharma, Inc. (GALE) - Earnings & Price History

GALE: Galena Biopharma, Inc. - 0.31, $11.92M, -0.01 (-2.82%)

Sector: Healthcare - Industry: Biotechnology

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs. The companys lead product candidate, NeuVax (nelipepimut-S), is in Phase III clinical trials for the prevention of recurrence in early- stage and node-positive breast cancer with low to intermediate human epidermal growth factor receptor (HER2) expression; Phase IIb clinical trials in combination with Herceptin for HER2 1+/2+ node-positive and high-risk node-negative breast cancer treatment; and Phase II clinical trials in combination with trastuzumab for node positive and negative HER2 IHC 3+ patients. It also develops GALE-301 (folate binding protein), which is in Phase IIa clinical trials for the prevention of recurrence in patients with ovarian and endometrial cancers; GALE-302, a version of the E39 peptide that is in Phase 1b cl

Past GALE reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-15AMC-0.520.620.58080.6350.60.689.33%-2.36%6.75%3.02M
2017-03-10AMC-0.52
2017-03-09AMC-0.520.5850.5820.5820.580.60.52%0.52%878.70K
2017-03-08AMC-0.520.5820.60030.610.560.611.62%-4.59%-3.05%1.82M
2016-11-09AMC-0.050.1960.1930.20250.1810.2194.92%-3.21%1.55%4.24M
2016-08-09AMC-0.060.43140.46220.450.420.46-2.64%-4.13%-6.66%7.29M
2016-05-10AMC-0.061.281.381.231.221.35-10.87%▲4.07%-7.25%1.24M
2016-03-10AMC-0.050.86160.88620.880.780.93-0.70%-2.09%-2.78%3.93M
2015-11-09AMC-0.071.531.721.471.371.54-14.53%4.08%-11.05%3.79M
2015-08-06AMC-0.091.511.631.551.461.59-4.91%-2.58%-7.36%2.88M
2015-05-07AMC-0.091.341.381.371.271.37-0.72%▲-2.19%-2.90%2.95M
2015-03-05AMC-0.111.8822.11.872.125.00%-10.48%-6.00%4.46M
2014-11-03AMCGalena Biopharm-0.13-0.111.991.9121.942.034.71%-0.50%4.19%1.23M
2014-08-11AMCGalena Biopharm-0.09-0.172.793.062.572.572.87-16.01%8.56%-8.82%2.96M
2014-05-06AMCGalena Biopharm-0.12.582.462.72.52.719.76%▲-4.44%4.88%3.93M
2014-03-18Galena Biopharm-0.09-0.133.082.822.92.823.262.84%6.21%9.22%9.07M
2013-11-12Galena Biopharm-0.1132.682.752.743.12.61%9.09%11.94%14.78M
2013-08-13Galena Biopharm-0.1-0.1121.962.041.992.064.08%-1.96%2.04%1.33M
2013-05-13Galena Biopharm-0.07-0.112.512.572.62.442.631.17%▲-3.46%-2.33%4.32M
2013-03-27Galena Biopharm-0.12.12.12.122.052.120.95%-0.94%1.45M
2012-11-13BMO-0.091.71.41.571.531.7812.14%8.28%21.43%5.29M
2012-08-14AMCQ2 2012 Galena Bioph-0.16-0.011.551.521.581.531.613.95%-1.90%1.97%1.12M
2012-05-15Galena Biopharm-0.12-0.091.251.121.131.11.280.89%▲10.62%11.61%1.59M
2012-05-14AMCQ1 2012 Galena Bioph-0.1-0.521.121.231.21.041.21-2.44%▲-6.67%-8.94%1.69M
2012-03-28AMCQ4 2011 Galena Bioph-0.150.042.2722.32.192.4515.00%-1.30%13.50%8.35M
2011-11-14Q3 2011 Rxi Pharmace-0.16-0.130.70.70.720.670.722.86%-2.78%142.70K
2011-08-16BMOQ2 2011 Rxi Pharmace-0.07-0.041.091.091.091.021.09241.80K
2011-05-17BMOQ1 2011 Rxi Pharmace0.880.90.910.840.921.11%▲-3.30%-2.22%700.60K
2011-03-31BMOQ4 2010 Rxi Pharmace-0.081.381.51.551.351.63.33%-10.97%-8.00%1.69M
2010-11-15BMOQ3 2010 RXi Pharmace-0.24-0.233.213.153.13.013.23-1.59%3.55%1.90%106.60K
2010-08-11BMOQ2 2010 RXi Pharmace-0.24-0.122.132.22.192.132.23-0.45%-2.74%-3.18%29.00K
2010-05-17Q1 2010 RXi Pharmace-0.27-0.244.454.424.414.44.51-0.23%▲0.91%0.68%194.10K
2010-03-31Q4 2009 RXi Pharmace-0.25-0.384.624.564.594.414.840.66%0.65%1.32%346.40K

Login | Register
Monday May 28, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades